BDBM50337927 (R)-5-(4-bromo-2-fluorophenylamino)-3-(2,3-dihydroxypropyl)-6-fluoro-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione::CHEMBL1684068::US8470837, 20

SMILES Cn1c2ncn(C[C@@H](O)CO)c(=O)c2c(Nc2ccc(Br)cc2F)c(F)c1=O

InChI Key InChIKey=BXCRAKOLCBQVDO-SECBINFHSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50337927   

TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50337927((R)-5-(4-bromo-2-fluorophenylamino)-3-(2,3-dihydro...)
Affinity DataIC50:  16nMAssay Description:Inhibition of MEK1 by IMAP assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDual specificity mitogen-activated protein kinase kinase 1 [2-31,52-393,S218E,S222D](Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50337927((R)-5-(4-bromo-2-fluorophenylamino)-3-(2,3-dihydro...)
Affinity DataIC50: >16nMpH: 7.3 T: 2°CAssay Description:Reaction product is determined quantitatively by fluorescent polarization using progressive IMAP beads from Molecular Devices.More data for this Ligand-Target Pair
In DepthDetails US Patent